請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74885
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鄭守夏 | |
dc.contributor.author | Pei-Shin Lo | en |
dc.contributor.author | 羅培心 | zh_TW |
dc.date.accessioned | 2021-06-17T09:09:32Z | - |
dc.date.available | 2021-03-12 | |
dc.date.copyright | 2020-03-12 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-10-16 | |
dc.identifier.citation | Akhlaq, A., McKinstry, B., Bin Muhammad, K., & Sheikh, A. (2016). Barriers and facilitators to health information exchange in low- and middle-income country settings: a systematic review. Health Policy and Planning, 31(9), 1310-1325. doi:10.1093/heapol/czw056
Allgulander, C. (1986). HISTORY AND CURRENT STATUS OF SEDATIVE-HYPNOTIC DRUG-USE AND ABUSE. Acta Psychiatrica Scandinavica, 73(5), 465-478. doi:10.1111/j.1600-0447.1986.tb02713.x Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H. D., Sanchezcraig, M., & Simpkins, J. (1986). PATTERNS OF BENZODIAZEPINE ABUSE AND DEPENDENCE. British Journal of Addiction, 81(1), 87-94. Carr, C. M., DiGioia, C. H., Wagner, J., & Saef, S. H. (2013). Primer in Health Information Exchange for the Emergency Physician: Benefits and Barriers. Southern Medical Journal, 106(6), 374-378. doi:10.1097/SMJ.0b013e318296ed67 Chan, D. C., Hao, Y. T., & Wu, S. C. (2009). Polypharmacy among Disabled Taiwanese Elderly A Longitudinal Observational Study. Drugs & Aging, 26(4), 345-354. doi:10.2165/00002512-200926040-00005 Chen, C. M., Kuo, L. N., Cheng, K. J., Shen, W. C., Bai, K. J., Wang, C. C., . . . Chen, H. Y. (2016). The effect of medication therapy management service combined with a national PharmaCloud system for polypharmacy patients. Computer Methods and Programs in Biomedicine, 134, 109-119. doi:10.1016/j.cmpb.2016.07.008 Cheng, J. S., Huang, W. F., Lin, K. M., & Shih, Y. T. (2008). Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. International Journal of Geriatric Psychiatry, 23(6), 618-624. doi:10.1002/gps.1950 Ciriello, J. N., & Kulatilaka, N. (2010). Smart Health Community: The Hidden Value of Health Information Exchange. American Journal of Managed Care, 16, SP31-SP36. Feng, X., Tan, X., Riley, B., Zheng, T. Y., Bias, T. K., Becker, J. B., & Sambamoorthi, U. (2017). Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries. Annals of Pharmacotherapy, 51(11), 981-989. doi:10.1177/1060028017717017 Finnell, J. T., & Overhage, J. M. (2010). Emergency medical services: the frontier in health information exchange. AMIA Annu Symp Proc, 2010, 222-226. Fontaine, P., Ross, S. E., Zink, T., & Schilling, L. M. (2010). Systematic Review of Health Information Exchange in Primary Care Practices. Journal of the American Board of Family Medicine, 23(5), 655-670. doi:10.3122/jabfm.2010.05.090192 Fulton, M. M., & Riley Allen, E. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123-132. doi:doi:10.1111/j.1041-2972.2005.0020.x Gerlach, L. B., Olfson, M., Kales, H. C., & Maust, D. T. (2017). Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Journal of the American Geriatrics Society, 65(9), 2052-2056. doi:10.1111/jgs.14930 Guilcher, S. J. T., Hogan, M. E., Calzavara, A., Hitzig, S. L., Patel, T., Packer, T., & Lofters, A. K. (2018). Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada. Spinal Cord, 56(11), 1059-1068. doi:10.1038/s41393-018-0174-z Hajak, G., Muller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003). Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98(10), 1371-1378. doi:10.1046/j.1360-0443.2003.00491.x Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007). Polypharmacy in elderly patients. The American Journal of Geriatric Pharmacotherapy, 5(4), 345-351. doi:https://doi.org/10.1016/j.amjopharm.2007.12.002 Heppner, H. J., Christ, M., Gosch, M., Muhlberg, W., Bahrmann, P., Bertsch, T., . . . Singler, K. (2012). Polypharmacy in the elderly from the clinical toxicologist perspective. Zeitschrift Fur Gerontologie Und Geriatrie, 45(6), 473-478. doi:10.1007/s00391-012-0383-6 Hincapie, A., & Warholak, T. (2011). The Impact of Health Information Exchange on Health Outcomes. Applied Clinical Informatics, 2(4), 499-507. doi:10.4338/aci-2011-05-r-0027 Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C. C., & King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162(2), 225-233. Hsieh, P. J., & Lin, W. S. (2018). Explaining resistance to system usage in the PharmaCloud: A view of the dual-factor model. Information & Management, 55(1), 51-63. doi:10.1016/j.im.2017.03.008 Huang, S. K., Wang, P. J., Tseng, W. F., Syu, F. K., Lee, M. C., Shih, R. L., . . . Chen, M. S. (2015). NHI-PharmaCloud in Taiwan-A preliminary evaluation using the RE-AIM framework and lessons learned. International Journal of Medical Informatics, 84(10), 817-825. doi:10.1016/j.ijmedinf.2015.06.001 Huang, W. F., & Lai, I. C. (2005). Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan. Drugs & Aging, 22(11), 957-965. doi:10.2165/00002512-200522110-00005 Ioachimescu, O. C., & El-Solh, A. A. (2012). Pharmacotherapy of insomnia. Expert Opinion on Pharmacotherapy, 13(9), 1243-1260. doi:10.1517/14656566.2012.683860 IOM report: Patient safety - Achieving a new standard for care. (2005). Academic Emergency Medicine, 12(10), 1011-1012. doi:10.1197/j.aem.2005.07.010 Johnson, K. B., Unertl, K. M., Chen, Q. X., Lorenzi, N. M., Nian, H., Bailey, J., & Frisse, M. (2011). Health information exchange usage in emergency departments and clinics: the who, what, and why. Journal of the American Medical Informatics Association, 18(5), 690-697. doi:10.1136/amiajnl-2011-000308 Kash, B. A., Baek, J., Davis, E., Champagne-Langabeer, T., & Langabeer, J. R. (2017). Review of successful hospital readmission reduction strategies and the role of health information exchange. International Journal of Medical Informatics, 104, 97-104. doi:10.1016/j.ijmedinf.2017.05.012 Kolhatkar, A., Cheng, L., Chan, F. K. I., Harrison, M., & Law, M. R. (2016). The impact of medication reviews by community pharmacists. Journal of the American Pharmacists Association, 56(5), 513-+. doi:10.1016/j.japh.2016.05.002 Kripke, D. F. (2000). Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Medicine Reviews, 4(1), 5-20. doi:10.1053/smrv.1999.0076 Kruse, C. S., Marquez, G., Nelson, D., & Palomares, O. (2018). The Use of Health Information Exchange to Augment Patient Handoff in Long-Term Care: A Systematic Review. Applied Clinical Informatics, 9(4), 752-771. doi:10.1055/s-0038-1670651 Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., Begaud, B., Verdoux, H., & Moore, N. (2004). Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology, 60(7), 523-529. doi:10.1007/s00228-004-0808-2 Lai, Y. R., Yang, Y. S., Tsai, M. L., Lu, Y. L., Kornelius, E., Huang, C. N., & Chiou, J. Y. (2016). Impact of potentially inappropriate medication and continuity of care in a sample of Taiwan elderly patients with diabetes mellitus who have also experienced heart failure. Geriatrics & Gerontology International, 16(10), 1117-1126. doi:10.1111/ggi.12606 Licata, S. C., & Rowlett, J. K. (2008). Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacology Biochemistry and Behavior, 90(1), 74-89. doi:10.1016/j.pbb.2008.01.001 Lin, J. H., & Cheng, S. H. (2018). The impact of a medication record sharing program among diabetes patients under a single-payer system: The role of inquiry rate. International Journal of Medical Informatics, 116, 18-23. doi:10.1016/j.ijmedinf.2018.05.004 Lin, S. C., Chen, C. C., Chen, Y. H., Chung, K. S., & Lin, C. H. (2011). Benzodiazepine prescription among patients with severe mental illness and co-occurring alcohol abuse/dependence in Taiwan. Human Psychopharmacology-Clinical and Experimental, 26(3), 201-207. doi:10.1002/hup.1193 Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivela, S. L., & Isoaho, R. (2002). Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology, 55(8), 809-817. doi:10.1016/s0895-4356(02)00411-0 Liu, M. C., & Lee, C. C. (2018). An Investigation of Pharmacists' Acceptance of NHI-PharmaCloud in Taiwan. Journal of Medical Systems, 42(11), 11. doi:10.1007/s10916-018-1017-3 Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57-65. doi:10.1517/14740338.2013.827660 Martin, E. (1985). Factors Affecting Primary Health-Care Utilization. Family Practice, 2(2), 122-123. doi:DOI 10.1093/fampra/2.2.122 Mastebroek, M., Naaldenberg, J., Lagro-Janssen, A. L., & de Valk, H. V. L. (2014). Health information exchange in general practice care for people with intellectual disabilities-A qualitative review of the literature. Research in Developmental Disabilities, 35(9), 1978-1987. doi:10.1016/j.ridd.2014.04.029 McCall, K. L., Tu, C. H., Lacroix, M., Holt, C., Wallace, K. L., & Balk, J. (2013). Controlled substance prescribing trends and physician and pharmacy utilization patterns: epidemiological analysis of the Maine Prescription Monitoring Program from 2006 to 2010. Journal of Substance Use, 18(6), 467-475. doi:10.3109/14659891.2012.685794 Menachemi, N., Rahurkar, S., Harle, C. A., & Vest, J. R. (2018). The benefits of health information exchange: an updated systematic review. Journal of the American Medical Informatics Association, 25(9), 1259-1265. doi:10.1093/jamia/ocy035 Mendelson, W. B., Roth, T., Cassella, J., Roehrs, T., Walsh, J. K., Woods, J. H., . . . Meyer, R. E. (2004). The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit Meeting Symposium. Sleep Medicine Reviews, 8(1), 7-17. doi:10.1016/s1087-0792(03)00042-x Morandi, A., Bellelli, G., Vasilevskis, E. E., Turco, R., Guerini, F., Torpilliesi, T., . . . Trabucchi, M. (2013). Predictors of Rehospitalization Among Elderly Patients Admitted to a Rehabilitation Hospital: The Role of Polypharmacy, Functional Status, and Length of Stay. Journal of the American Medical Directors Association, 14(10), 761-767. doi:10.1016/j.jamda.2013.03.013 Morgan, S. G., Cunningham, C. M., & Hanley, G. E. (2010). Individual and Contextual Determinants of Regional Variation in Prescription Drug Use: An Analysis of Administrative Data from British Columbia. Plos One, 5(12). doi:ARTN e15883 10.1371/journal.pone.0015883 Neutel, C. I., Skurtveit, S., & Berg, C. (2012). Polypharmacy of potentially addictive medication in the older personsuquantifying usage. Pharmacoepidemiology and Drug Safety, 21(2), 199-206. doi:10.1002/pds.2214 Office of the National Coordinator for Health Information Technology. Health Information Exchange (HIE): What is HIE? (2014). Passarella, S., & Duong, M. T. (2008). Diagnosis and treatment of insomnia. American Journal of Health-System Pharmacy, 65(10), 927-934. doi:10.2146/ajhp060640 Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., . . . Ghali, W. A. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care, 43(11), 1130-1139. Rudin, R. S., Motala, A., Goldzweig, C. L., & Shekelle, P. G. (2014). Usage and Effect of Health Information Exchange A Systematic Review. Annals of Internal Medicine, 161(11), 803-U897. doi:10.7326/M14-0877 Sadoughi, F., Nasiri, S., & Ahmadi, H. (2018). The impact of health information exchange on healthcare quality and cost-effectiveness: A systematic literature review. Computer Methods and Programs in Biomedicine, 161, 209-232. doi:10.1016/j.cmpb.2018.04.023 Shah, B. M., & Hajjar, E. R. (2012). Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes. Clinics in Geriatric Medicine, 28(2), 173-+. doi:10.1016/j.cger.2012.01.002 Sharma, S., Kukreti, P., & Kataria, D. (2018). Sedative hypnotics overdose: Epidemiology, diagnosis and management. Indian Journal of Medical Specialities, 9(3), 134-139. doi:10.1016/j.injms.2018.04.009 Shimura, A., Takaesu, Y., Aritake, S., Futenma, K., Komada, Y., & Inoue, Y. (2016). Later sleep schedule and depressive symptoms are associated with usage of multiple kinds of hypnotics. Sleep Medicine, 25, 56-62. doi:10.1016/j.sleep.2016.04.011 Sonnenberg, C. M., Bierman, E. J. M., Deeg, D. J. H., Comijs, H. C., van Tilburg, W., & Beekman, A. T. F. (2012). Ten-year trends in benzodiazepine use in the Dutch population. Social Psychiatry and Psychiatric Epidemiology, 47(2), 293-301. doi:10.1007/s00127-011-0344-1 Straand, J., & Rokstad, K. (1997). General practitioners' prescribing patterns of benzodiazepine hypnotics: Are elderly patients at particular risk for overprescribing? A report from the More & Romsdal Prescription Study. Scandinavian Journal of Primary Health Care, 15(1), 16-21. doi:10.3109/02813439709043423 Sundseth, A. C., Gjelstad, S., Straand, J., & Rosvold, E. O. (2018). General practitioners' prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study. Scandinavian Journal of Primary Health Care, 36(2), 115-122. doi:10.1080/02813432.2018.1459164 Tseng, Y. T., Chang, E. H., Kuo, L. N., Shen, W. C., Bai, K. J., Wang, C. C., & Chen, H. Y. (2017). Preliminary physician and pharmacist survey of the National Health Insurance PharmaCloud system in Taiwan. Computer Methods and Programs in Biomedicine, 149, 69-77. doi:10.1016/j.cmpb.2017.07.004 Vest, J. R., & Jasperson, J. (2010). What should we measure? Conceptualizing usage in health information exchange. Journal of the American Medical Informatics Association, 17(3), 302-307. doi:10.1136/jamia.2009.000471 Wagner, J., & Wagner, M. L. (2000). Non-benzodiazepines for the treatment of insomnia. Sleep Medicine Reviews, 4(6), 551-581. doi:10.1053/smrv.2000.0126 Wang, L. J., Chen, Y. C., Chen, C. K., Chou, W. J., & Chou, M. C. (2014). Trends in Anxiolytic-Hypnotic Use and Polypharmacy in Taiwan, 2002-2009: A Nationwide, Population-Based Survey. Psychiatric Services, 65(2), 208-214. doi:10.1176/appi.ps.201300066 WHO. (2019). ATC/DDD Index 2019. Retrieved from https://www.whocc.no/atc_ddd_index/ 中央健康保險署中區業務組. (2015). 「雲端藥歷系統」暨「門診特定藥品重複用藥費用核扣方案」. Retrieved from http://www.tccpa.org.tw/img/images/1041230.pdf. 王心榆, & 施雅分. (2017). 雲端藥歷再升級!!「健保醫療資訊雲端系統」介紹. 彰基藥訊, 25(2), 7-8. 王慧瑜, 葉明功, 胡明寬, 陳建銘, & 湯松陵. (2016). 運用門診雲端藥歷進行藥事照護與藥物相關問題探討. [Use of Out-Patient Prescription Data in PharmaCloud System and Investigate Potential Drug Related Problems]. 臺灣臨床藥學雜誌, 24(3), 194-208. doi:10.6168/fjcp.2016.2403.04 全國法規資料庫. Retrieved from https://law.moj.gov.tw 行政院衛生署中央健康保險局. (2012a). 全民健康保險藥品給付規定. 行政院衛生署中央健康保險局. (2012b). 增訂全民健康保險檔案分析審查異常不予支付指標及處理方式. Retrieved from https://www.google.com/url?client=internal-uds-cse&cx=015315884041405855827:ixioug6-75o&q=http://www.nhi.gov.tw/Resource/bulletin/4035_1010075197A-5.pdf&sa=U&ved=2ahUKEwj9noDn9tbiAhUN7LwKHWSHDhQQFjAAegQIBBAB&usg=AOvVaw0ovtSMwL1dFY-aRzwToP1h 李欣雅, 劉建宏, & 李志恒. (2010). 台灣常見管制藥品之使用與管理. [Use and Management of Common Controlled Drugs in Taiwan]. 台灣醫學, 14(6), 627-636. doi:10.6320/fjm.2010.14(6).05 沈茂庭, & 劉家慧. (2009). 健保局對安眠藥管制藥品的管理與努力. 醫療品質雜誌, 3(4), 33-35. doi:10.30160/jhq.200907.0007 阮建維, 謝碧容, & 王柏為. (2015). 延伸科技接受理論模型探討醫師對於健保雲端藥歷的行為意圖. [Physicians’ behavioral intentions toward the NHI PharmaCloud: An extension of the technology acceptance model]. 醫療資訊雜誌, 24(3), 27-36. 郭淑珍, 陳怡君, & 楊雪華. (2012). 醫師的安眠藥物處方行為之初探:一項質性研究. [A preliminary investigation of hypnotic prescribing behavior by physicians: a qualitative study]. 台灣公共衛生雜誌, 31(6), 556-569. doi:10.6288/tjph2012-31-06-07 黃仁享, & 盧言珮. (2013). 從「保險對象特定醫療資訊查詢平台」之設置談用藥安全. 臺灣醫界, 56(1), 8-10. 黃玉如, 張意宜, & 蘇渝評. (2012). 某教學醫院抗焦慮作用BZDs之處方合理性分析. [Analysis of Anti-Anxiety BZDs Utilization in A Teaching-Hospital]. 臺灣臨床藥學雜誌, 20(2), 103-113. 廖玲嬋, 廖光明, & 黃曉鳳. (2016). 雲端藥歷初期成效分析. [The Early Results Analysis of PharmaCloud System]. 醫療品質雜誌, 10(6), 67-72. 劉存濱, 謝碧容, & 許時涵. (2014). 探討醫師及藥師對健保雲端藥歷系統期望和感受之間的差異分析. [Discrepancies between Desired and Perceived Measures of Performance of the National Health Insurance PharmaCloud System by Physicians and Pharmacists]. 健康管理學刊, 12(2), 52-66. 衛生福利部. (2013). 回應媒體「濫用安眠藥嚴重」報導. 衛生福利部中央健康保險署. 健康保險資料開放服務. Retrieved from https://www.nhi.gov.tw/Default.aspx 衛生福利部中央健康保險署. (2010). 健保局節流措施--高診次民眾輔導成效. 衛生福利部中央健康保險署. (2018). 107年全民健康保險高診次者藥事照護計畫. Retrieved from http://sc-dr.tw/shangchan/upload/files/107%E5%B9%B4%E5%85%A8%E6%B0%91%E5%81%A5%E5%BA%B7%E4%BF%9D%E9%9A%AA%E9%AB%98%E8%A8%BA%E6%AC%A1%E8%80%85%E8%97%A5%E4%BA%8B%E7%85%A7%E8%AD%B7%E8%A8%88%E7%95%AB.pdf. 鄭淑文. (2012). 精神專科醫院門診鎮靜安眠藥處方之探討. [A Study on the Outpatient Prescriptions of Sedatives and Hypnotics in a Mental Hospital]. 臺灣臨床藥學雜誌, 20(3), 181-194. 行政院衛生署. (2004). 苯二氮平類(BENZODIAZEPINES)藥品用於鎮靜安眠之使用指引. Retrieved from https://www.fda.gov.tw/upload/46/%E8%8B%AF%E4%BA%8C%E6%B0%AE%E5%B9%B3%E9%A1%9E%E4%B9%8B%E5%85%AC%E5%91%8A_961003%E5%85%AC%E5%91%8A%E4%BF%AE%E8%A8%82.pdf. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74885 | - |
dc.description.abstract | 背景:
國內外有許多關於醫師開立安眠藥處方、病患使用安眠藥、重複用藥之研究,顯示臺灣安眠藥重複領藥問題的重要性。2013年衛生福利部中央健康保險署實施「健保醫療資訊雲端查詢系統」,是政府解決重複用藥問題之因應政策。因此,本研究藉由探討健保醫療資訊雲端查詢系統與安眠藥重複用藥之相關性,作為檢驗健保醫療資訊雲端查詢系統政策效果。 目的: 目的一為評估健保醫療資訊雲端查詢系統介入後,對安眠藥重複處方天數及處方情形的影響;目的二則是探討健保醫療資訊雲端查詢系統實施後,新北市安眠類管制藥品健保調劑藥品是否流為自費調劑。 方法: 採用單組前後測設計,藉由觀察2013年健保醫療資訊雲端查詢系統實施前,與2016年實施健保醫療資訊雲端查詢統之後安眠藥處方使用的變化,來瞭解政策實施之效果。目的一係利用全人口健保資料取得處方劑量、平均每張處方安眠藥品種類及重覆處方天數;目的一樣本共有兩個族群,分別為全國門、急診曾經使用安眠藥的患者,以及全國門、急診三年均使用安眠藥的個案,進行描述性統計分析比較此兩組樣本,接著利用廣義估計方程式分析2016年實施健保資訊雲端查詢系統之後相較2013年實施健保資訊雲端查詢系統之前,後者處方劑量、平均每張處方安眠藥品種類及重複處方情形之變化。目的二亦區分為全國及新北市安眠藥調劑機構兩組樣本進行比較,健保調劑劑量是來自全人口健保資料庫,而新北市的自費調劑率是從管制藥品管理資訊系統取得的調劑總量及前述健保調劑劑量計算得之,接著剖析2016年實施健保醫療資訊雲端查詢系統之後,相較於2013年實施前自費調劑率之趨勢變化。 結果: 目的一樣本群體層次部分,全國門急診安眠藥使用者使用人數約占全國人口5%,其中有四分之一有重複處方情形,2016年的重複率為17.3%,較2013年減少了4.16%,每人平均重複處方天數在2013年為15.348日,到2016年下降到10.531日;全國門急診安眠類長期使用者計91,079人,其中有四至五成有重複處方情形,2016年的重複率為39.74%,較2013年減少了10.62%,每人平均重複處方天數在2013年為30.04日,到2016年下降到17.14日。個體層次部分,2016年重複處方的機率為2013年的0.681倍(p<0.0001),2013年至2016年重複處方機率下降幅度較大; 2016年的重複處方天數顯著較2013年低43.01%(p<0.0001),2013年至2016年下降的幅度較2010年至2013年稍少。 另外在目的二的樣本部分,新北市的自費調劑率在2010年為19.19%、2013年為16.22%,2016年則13.76%,其中2013年較2010年減少2.97 %,2016年較2013減少2.46%,降低的幅度差不多。 結論: 健保醫療資訊雲端查詢系統可能有效減緩處方劑量、安眠藥併用機率的上升趨勢,以及降低重複處方率,而自費調劑率未因政策介入增加,不過仍須注意安眠藥使用者盛行率上升趨勢之原因,建議加強重複用藥的管制方式,並進一步研究與監控,以避免安眠藥囤積,導致成癮性藥品流為非法用途使用。 | zh_TW |
dc.description.abstract | Background: Many studies have addressed the prescription behaviors of hypnotics, patients’ utilization patterns of hypnotics, and duplicated medication of hypnotics, and pointed out the significance of duplicated medication in Taiwan. To tackle this problem, National Health Insurance Administration implemented a health information exchange system, entitled “PharmaCloud,” in 2013. In this regard, this study aims to examine the association between “PharmaCloud” and duplicated medication of hypnotics before and after the “PharmaCloud” program.
Objective: The study aimed to evaluate the influence of the 2013 “PharmaCloud” program on the prescription, overlapping days and out-of-pocket utilizations related to hypnotics. Through the evaluation, this study is able to further examine whether the policy of “PharmaCloud” turns the controlled medication of hypnotics covered by health insurance into out-of-pocket prescriptions. Methods: One group pre- and post-test design is adopted to examine the trend prior to the introduction of “PharmaCloud” and the changes and effects after the implementation of this policy. To do so, this study extracts the information from National Health Insurance database to access the prescription dosage, the average types of hypnotics within each prescription, and overlapping days of hypnotics. The samples of this study for analysis are divided into two groups, respectively those who once used hypnotics and those who used hypnotics throughout 2010, 2013 and 2016, based on the users of hypnotics in nationwide out-patient clinics and emergency service departments. Then descriptive statistics is used to compare these two sets of samples: the latter sample is kept under track and observation for estimating the changes of prescription quantity, the average medication types of each prescription, and the situation of duplicated medication of hypnotics by using Generalized estimating equation (GEE). Secondly, we divide the region into nationwide and New Taipei City hypnotics-prescribing organizations for conducting a comparative study, with the quantity of hypnotics covered by health insurance extracted from National Health Insurance database and the out-of-pocket rate of prescription derived from the total dispensed quantity of hypnotics in New Taipei City from Controlled Drugs Management Information System. Subsequently we observe the trend change of out-of-pocket prescription rates prior to the implementation of “PharmaCloud” in 2013 and after its implementation in 2016. Results: In the samples of set I, the hypnotics users across nationwide out-patient and emergency visits accounts for 5% of total population, with one-quarter of them had duplicated medication. The rate of duplicated medication in 2016 is 17.3%, and a reduction of 4.16% compared with that in 2013. The average overlapping days drops from 15.348 days in 2013 to 10.531 days in 2016. The sub-sample of continuous users of hypnotics during 2010 and 2016 consisted of 91,079 people, with forty to fifty percent of samples having duplicated medication; the duplication rate in 2016 is 39.74%, and 10.62% less than that in 2013, with the average overlapping days per capita decreasing from 30.04 days in 2013 to 17.14 days in 2016. At individual level, the probability of duplicated medication in 2016 is 0.681 times (p<0.0001) that in 2013, with a steeper slope of drop rate from 2013 to 2016; the overlapping days in 2016 is significantly shorter than that in 2013 by 43.01% (p<0.0001), with a milder slope of drop in 2013-2016 compared to that in 2010-2013. In the sample of set II, the out-of-pocket rate of prescription in New Taipei City is 19.19% in 2010, 16.22% in 2013, and 13.76% in 2016, respectively. There is a reduction of 2.97% during 2010-2013 and a reduction of 2.46% during 2013-2016, revealing a similar extent of dropping. Conclusions: PharmaCloud may have effectively alleviated the rising trend of prescription quantity, of polypharmacy with hypnotics, and lower duplicated medication rate. On the other hand, the quantity of out-of-pocket prescription did not increase with the interference of the policy. The causes behind the rising trend of hypnotic usage still deserve further investigation, implying the needs of stricter regulation over duplicated medication to prevent stockpiling of hypnotics and the illegal usage of addictive drugs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T09:09:32Z (GMT). No. of bitstreams: 1 ntu-108-R06848024-1.pdf: 2634505 bytes, checksum: 270e9e95d0453726267a4d0703f8c85c (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 第一章 緒論 1
第一節 研究背景與動機 1 第二節 研究目的 3 第三節 研究重要性 3 第二章 文獻探討 5 第一節 健保醫療資訊雲端查詢系統 5 第二節 管制藥品的管理與申報 18 第三節 鎮靜安眠藥的治療與處方情形 21 第四節 安眠藥重複處方與危害 26 第五節 管制藥品重複領取防制政策 32 第六節 文獻小結 33 第三章 研究材料與方法 36 第一節 研究目的一:研究架構與假說 36 第二節 研究目的一:資料來源與研究對象 39 第三節 研究目的一:研究變項 43 第四節 研究目的一:資料處理與統計分析 52 第五節 研究目的二:研究概念、架構與假說 58 第六節 研究目的二:資料來源與研究對象 59 第七節 研究目的二:研究變項 61 第八節 研究目的二:資料處理與統計分析 64 第四章 研究結果 67 第一節 安眠藥使用情形的全國趨勢 67 第二節 健保醫療資訊雲端查詢系統效果檢視 71 第三節 安眠藥健保調劑劑量的全國趨勢 116 第四節 分析新北市自費處方的變化 120 第五章 討論 132 第一節 處方行為與影響因子 132 第二節 健保醫療資訊雲端查詢系統的政策效果 135 第三節 新北市安眠藥自費開立率的探討 138 第四節 研究限制 140 第六章 結論與建議 142 第一節 結論 142 第二節 建議 143 | |
dc.language.iso | zh-TW | |
dc.title | 探討健保醫療資訊雲端查詢系統對安眠藥使用的影響 | zh_TW |
dc.title | The influence of PharmaCloud program on hypnotics utilization | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊銘欽,蔡淑鈴 | |
dc.subject.keyword | 健保醫療資訊雲端查詢系統,安眠藥,重複處方,自費, | zh_TW |
dc.subject.keyword | PharmaCloud,hypnotics,duplicated medication,out-of -pocket, | en |
dc.relation.page | 157 | |
dc.identifier.doi | 10.6342/NTU201904205 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-10-16 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 2.57 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。